glp-1 news oct 16 2025 in three charts: sticky adoption and what's next Who Gets the Shot? GLP-1
Description
The glucagon component is especially relevant for liver fat
Their lives were high-stress, sleep-starved, and increasingly hopeless
Lancet (2017) 390:166475
consider delaying elective surgery
Fen-phen was marketed as an effective weight loss drug in the 1990s but later pulled from the market due to its link to severe heart and lung problems, including pulmonary hypertension and heart valve damage
